MENU
ALMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alumis (ALMS) Ownership - Who owns Alumis?
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
323.43M
P/E Ratio
N/A
Total Cash
208.75M
Projected Growth
N/A
Total Debt
31.88M
Revenue
17.39M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.03
Total Debt/Equity
N/A
Revenue/Share
0.32 USD as % of share price
Fundamentals
ALMS
Capitalization
323M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
209M
Total Cash/Share
2.03
Total Debt
31.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.32%
Revenue
17.4M
ROE
N/A
Book Value
168M
P/B Ratio
1.92
Cash Flow
N/A
Earnings
-11.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.73
Current Revenue Per Employee
94505.44
Dividends Per Share - Security
N/A
EBITDA
-354.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-156.54
Shares Held By Institutions
215M
Shares Outstanding - Current
103M
Total Liabilities
93M
Total Volume MTD
N/A
Value
1
Gain YTD
-60.051
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information